Merck

Yahoo Finance • 4 hours ago

Organon (OGN) Climbs 39% on $12-Billion Merger Buzz

Organon & Co. (NYSE:OGN) is one of the 10 Stocks Powering Portfolios by Double Digits. Organon surged by 38.8 percent week-on-week, as investors gobbled up shares following reports that it is set to be acquired by Sun Pharmaceutical Indus... Full story

Yahoo Finance • yesterday

Catalyst Watch: Earnings heat up, Fedspeak flurry, and eyes on space

[Wall street and Broadway road sign in New York City] Welcome to Seeking Alpha's Catalyst Watch - a breakdown of some of next week's actionable events that stand out. Read more about the events that may impact stock prices next week. MON... Full story

Yahoo Finance • 2 days ago

Nvidia Who? This Highflyer Keeps Popping Onto This Elite Screen

While Nvidia once again fails to make the list, the best mutual funds keep scooping up shares this one stock. Continue Reading... Full story

Yahoo Finance • 2 days ago

Novel Drugs Approved By The FDA In 2025

(RTTNews) - The U.S. Food and Drug Administration (FDA) in 2025 approved 46 novel drugs, including 34 new molecular entities (NMEs) and 12 biologics. The approved drugs treated indications ranging from advanced or refractory breast and lun... Full story

Yahoo Finance • 2 days ago

Biopharma Stocks Largely Exempt From Pharma Tariffs, BofA Says

Large-cap and small- to medium-cap biopharmaceutical companies in BofA Securities' coverage are not PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premium... Full story

Yahoo Finance • 3 days ago

Medicenna Therapeutics Appoints Dr. Nageatte Ibrahim as Chief Medical Officer

Medicenna Therapeutics Corp. TORONTO and HOUSTON, April 09, 2026 (GLOBE NEWSWIRE) -- Medicenna Therapeutics Corp. (“Medicenna” or the “Company”) (TSX: MDNA, OTCQX: MDNAF), a clinical-stage immunotherapy company focused on the development... Full story

Yahoo Finance • 3 days ago

Assessing Merck (MRK) Valuation After Strong Recent Share Price Momentum

Never miss an important update on your stock portfolio and cut through the noise. Over 7 million investors trust Simply Wall St to stay informed where it matters for FREE. Merck stock performance snapshot Merck (MRK) has drawn fresh atte... Full story

Yahoo Finance • 4 days ago

Is Merck & Co. (MRK) One of the Best Consistent Dividend Stocks to Buy Right Now?

Merck & Co., Inc. (NYSE:MRK) is included among the 15 Best Consistent Dividend Stocks to Buy Right Now.Is Merck & Co. (MRK) One of the Best Consistent Dividend Stocks to Buy Right Now? On April 6, JPMorgan analyst Chris Schott raised the... Full story

Yahoo Finance • 4 days ago

Phanes Therapeutics announces dose expansion in clinical study of spevatamig in combination with chemotherapy for treatment of biliary tract cancer

SAN DIEGO, April 7, 2026 /PRNewswire/ -- Phanes Therapeutics, Inc. (Phanes), a clinical stage biotech company focused on innovative drug discovery and development in oncology, announced today the initiation of the dose expansion phase in t... Full story

Yahoo Finance • 4 days ago

Merck’s Terns Deal Targets Cancer Pipeline And Keytruda Patent Risks

Get insights on thousands of stocks from the global community of over 7 million individual investors at Simply Wall St. Merck (NYSE:MRK) has agreed to acquire Terns Pharmaceuticals in a deal aimed at expanding its oncology and hematology... Full story

Yahoo Finance • 4 days ago

TCW Relative Value Large Cap Fund Sold Alphabet Inc (GOOG) After Meeting Valuation Characteristics

TCW funds, an investment management company, released its “TCW Relative Value Large Cap Fund” fourth-quarter 2025 investor letter. A copy of the letter can be downloaded here. Equities ended the year on a positive note, with the S&P 500 To... Full story

Yahoo Finance • 4 days ago

Intel Corporation (INTC) Surged Following the Announcement of a Partnership With NVIDIA

TCW funds, an investment management company, released its “TCW Relative Value Large Cap Fund” fourth-quarter 2025 investor letter. A copy of the letter can be downloaded here. Equities ended the year on a positive note, with the S&P 500 To... Full story

Yahoo Finance • 5 days ago

Strong Results Lifted Merck & Co (MRK) in Q4

TCW funds, an investment management company, released its “TCW Relative Value Large Cap Fund” fourth-quarter 2025 investor letter. A copy of the letter can be downloaded here. Equities ended the year on a positive note, with the S&P 500 To... Full story

Yahoo Finance • 5 days ago

Is It Too Late to Buy Costco or Merck? Are These Defensive Stocks Overbought?

Quick Read Costco (COST) trades at a forward P/E of 50x with an RSI well below overbought levels, supported by fiscal Q2 revenue growth of 9.22% and 22.6% digital comparable sales growth, while Merck (MRK) cooled from an RSI of 77 and gen... Full story

Yahoo Finance • 5 days ago

Merck Begins Tender Offer to Acquire Terns Pharmaceuticals, Inc.

RAHWAY, N.J., April 07, 2026--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside of the United States and Canada, is commencing today, through a subsidiary, a cash tender offer to purchase all outstanding shares of common stock of Te... Full story

Yahoo Finance • 5 days ago

Enliven (ELVN) Gets Higher Price Targets From H.C. Wainwright and Mizuho

Enliven Therapeutics, Inc. (NASDAQ:ELVN) is one of the 10 Best Performing Stocks of Q1 2026 to Watch for Q2. On March 26, H.C. Wainwright increased its price target on Enliven Therapeutics, Inc. (NASDAQ:ELVN) from $48 to $56 and kept its B... Full story

Yahoo Finance • 8 days ago

Trump Unveils Up to 100% Tariffs on Imported Medicines With Key Exemptions

This article first appeared on GuruFocus. The Trump administration is moving forward with a tariff framework that could reshape global pharmaceutical trade, imposing duties of up to 100% on certain imported patented medicines while embedd... Full story

Yahoo Finance • 9 days ago

Mental Health Market Set to Surpass USD 668.62 Billion by 2035, Owing to the Increased Adoption of Digital Care and AI-Driven Therapies – SNS Insider

Austin, United States, April 03, 2026 (GLOBE NEWSWIRE) -- As per SNS Insider, The global Mental Health Market was estimated at USD 449.96 billion in 2025 and is projected to hit USD 668.62 billion by 2035, recording a CAGR of 4.04% over... Full story

Yahoo Finance • 10 days ago

Merck & Co. (MRK) Announces Detailed Results From the Phase 2 CADENCE Study

Merck & Co., Inc. (NYSE:MRK) is one of the best pharma stocks to invest in now. On March 29, Merck & Co., Inc. (NYSE: MRK) announced detailed results from the Phase 2 CADENCE study designed to evaluate the efficacy, safety, and tolerabilit... Full story

Yahoo Finance • 10 days ago

Lilly Pushes Back on Making Drug Price Deals Permanent

This article first appeared on GuruFocus. Eli Lilly (LLY, Financials) is drawing a clear line in the ongoing debate over drug pricing, warning that making current agreements permanent could create bigger problems down the road. Warning!... Full story